Bjørn Tore Gjertsen

Overview

Best Publications

• Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells

  Jonathan M Irish;Randi Hovland;Peter O Krutzik;Omar D Perez

  847
  Citations

• Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.

  Christine Gjerdrum;Crina Tiron;Torill Høiby;Ingunn Stefansson

  626
  Citations

• Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

  Tea Pemovska;Mika Kontro;Bhagwan Yadav;Henrik Edgren

  455
  Citations

• A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer

  Georg Gjorgji Dimcevski;Spiros Kotopoulis;Tormod Karlsen Bjånes;Dag Hoem

  413
  Citations

• The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells.

  Roald Bøe;Bjørn Tore Gjertsen;Olav Karsten Vintermyr;Gunnar Houge

  411
  Citations

• Inherited Mutations in PTEN That Are Associated with Breast Cancer, Cowden Disease, and Juvenile Polyposis

  Eric D. Lynch;Elizabeth A. Ostermeyer;Ming K. Lee;J. Fernando Arena

  342
  Citations

• Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients

  Sigbjørn Berentsen;Elling Ulvestad;Bjørn Tore Gjertsen;Henrik Hjorth-Hansen

  334
  Citations

• Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action.

  B T Gjertsen;G Mellgren;A Otten;E Maronde

  279
  Citations

• Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia.

  Robert J. Kreitman;Claire Dearden;Pier Luigi Zinzani;Julio Delgado

  251
  Citations

• SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells

  Ling Li;Tereza Osdal;Yinwei Ho;Sookhee Chun

  246
  Citations

• Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy.

  Bjorn T Gjertsen;Patrick Schöffski

  218
  Citations

• The genetic subtypes of cAMP-dependent protein kinase--functionally different or redundant?

  Stein O. Døskeland;Erik Maronde;Bjørn T. Gjertsen

  209
  Citations

• Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells

  O. Bruserud;C. Stapnes;E. Ersvær;B. T. Gjertsen

  182
  Citations

• Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors

  K. E. Fladmark;Odd Terje Brustugun;R. Hovland;R. Bøe

  170
  Citations

• Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial

  Cecilie Gudveig Gjerde;Kamal Babikeir Eln Mustafa;Sølve Hellem;Markus Rojewski

  170
  Citations

• New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches.

  Øystein Bruserud;Bjørn Tore Gjertsen;Brynjar Foss;Tien-Sheng Huang

  161
  Citations

• Fine Mapping of 28S rRNA Sites Specifically Cleaved in Cells Undergoing Apoptosis

  G Houge;B Robaye;T S Eikhom;J Golstein

  148
  Citations

• Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease.

  Sigbjørn Berentsen;Geir E. Tjønnfjord;Robert Brudevold;Bjørn T. Gjertsen

  147
  Citations

• The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells.

  Camilla Stapnes;Anne P. Døskeland;Kimberley Hatfield;Elisabeth Ersvær

  146
  Citations

• Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities

  Øystein Bruserud;Randi Hovland;Line Wergeland;Tien-Sheng Huang

  146
  Citations